Why is Nvidia’s market cap hitting $4 trillion?
How will Trump’s Brazil tariffs impact US prices?
What caused Ford’s massive US vehicle recall?
Why is Tesla expanding Robotaxi service in Phoenix?
How did Delta restore its profit outlook?
What’s behind Indeed and Glassdoor job cuts?
Why is Amazon considering more investment in Anthropic?
Why Is AbbVie Stock Trading Higher On Thursday?
benzinga.com/markets/biotech/25/07/46352525/why-is-abbvie-stock-trading-higher-on-thursday
IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. (NYSE:ABBV), on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform,…
This story appeared on benzinga.com, 2025-07-10 18:36:41.